This research develops injectable, enzyme-coated gel beads to treat bone fractures non-invasively. Using lab-on-a-chip technology, the beads trigger clot formation at injury sites, supporting natural healing while providing structural stability. This approach could reduce reliance on surgery, improve recovery outcomes, and address non-healing fractures affecting millions annually.

This research presents an anti-inflammatory surgical gel that actively reprograms the immune response at the injury site. Rather than masking symptoms, it promotes proper healing, reduces prolonged inflammation, and improves recovery—especially for patients with delayed healing, such as those with diabetes—aligning biomaterials with modern surgical precision.